Design and synthesis of substrate-based inhibitors of botulinum neurotoxin type B metalloprotease

Biopolymers. 2003;71(6):602-19. doi: 10.1002/bip.10590.

Abstract

Botulinum toxin (BoNT) metalloproteases and related proteases are the most selective proteases known. X-ray crystal structures suggest that the native enzymes exist in catalytically incompetent forms that must be activated by substrate binding. In order to characterize the postulated substrate-induced conformational changes, we synthesized a series of transition state analog inhibitors (TSI) in which the dipeptide cleavage site has been replaced by tetrahedral intermediate analogs within the minimal substrate peptide sequence. Reduced amide, alpha-hydroxyamide, alpha-thio-amide, and hydroxyethylamine analogs of -Gln-Phe- were incorporated via solid phase peptide synthesis into 35-mer analogs of the minimal peptide substrate sequence. The synthesis, characterization, and inhibition kinetics for four series of compounds against holotoxin BoNT/B is described. The alpha-thiol amide derivatives of the 35-mer substrate were found to inhibit BONT/B in the low micromolar range.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Botulinum Toxins / antagonists & inhibitors*
  • Drug Design
  • Metalloproteases / antagonists & inhibitors*
  • Models, Molecular
  • Molecular Sequence Data
  • Protease Inhibitors / chemical synthesis*
  • Protease Inhibitors / pharmacology*
  • Substrate Specificity

Substances

  • Protease Inhibitors
  • Metalloproteases
  • Botulinum Toxins